• Feb 12, 2025

Hedge Fund Run by Former Argentina Economic Chief Posts 22% Gain

(Bloomberg) -- Nicolas Dujovne resigned as Argentina’s top economic policymaker in 2019, as a chaotic post-election selloff shook the country’s assets over fears that the pro-business policies of President Mauricio Macri were coming to an end.Most Read from BloombergSaudi Arabia’s Neom Signs $5 Billion Deal for AI Data CenterWhy American Mobility Ground to a HaltThe Forgotten French Architect Who Rebuilt MarseilleIn New Orleans, an Aging Dome Tries to Stay SuperMore than five years later, a bond

  • Feb 12, 2025

Hot Jan US CPI surprise argues for Fed staying in neutral

The CPI jumped 0.5% last month after gaining 0.4% in December, the Labor said on Wednesday. Economists polled by Reuters had forecast the CPI gaining 0.3% and rising 2.9% year-on-year. Fed funds futures showed traders do not expect another Fed ease until at least September, having shown before the report expectations for a 25 basis point cut in June.

  • Feb 12, 2025

OPEC sticks to 2025, 2026 global oil demand growth forecasts

OPEC on Wednesday stuck to its forecast for relatively strong growth in global oil demand in 2025, saying air and road travel would support consumption and potential trade tariffs were not expected to impact economic growth. The Organization of the Petroleum Exporting Countries, in a monthly report, said world oil demand will rise by 1.45 million barrels per day (bpd) in 2025 and by 1.43 million bpd in 2026. Both forecasts were unchanged from last month.

  • Feb 12, 2025

US consumer inflation increases at fastest pace in nearly 1-1/2 years in January

WASHINGTON (Reuters) -U.S. consumer prices increased by the most in nearly 1-1/2 years in January, with Americans facing higher costs for a range of goods and services, reinforcing the Federal Reserve's message that it was in no rush to resume cutting interest rates amid growing uncertainty over the economy. The hotter-than-expected inflation reported by the Labor Department on Wednesday was likely partly due to businesses raising prices at the start of the year, evident in a record surge in the cost of prescription medication and an increase in motor vehicle insurance. The report followed a pattern of CPI numbers overshooting expectations every January, which some economists said suggested that the seasonal adjustment factors, the model used by the government to strip out seasonal fluctuations from the data, were not fully accounting for the one-off turn-of-year price hikes.

  • Feb 12, 2025

Biogen’s (NASDAQ:BIIB) Q4 Sales Top Estimates

Biotech company Biogen (NASDAQ:BIIB) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 2.9% year on year to $2.45 billion. Its non-GAAP profit of $3.44 per share was 2.3% above analysts’ consensus estimates.